Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 1/2019

01-02-2019 | Invited Review

Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules

Authors: Nicolas Faller, Nasser A. Dhayat, Daniel G. Fuster

Published in: Urolithiasis | Issue 1/2019

Login to get access

Abstract

Twin and genealogy studies suggest a strong genetic component of nephrolithiasis. Likewise, urinary traits associated with renal stone formation were found to be highly heritable, even after adjustment for demographic, anthropometric and dietary covariates. Recent high-throughput sequencing projects of phenotypically well-defined cohorts of stone formers and large genome-wide association studies led to the discovery of many new genes associated with kidney stones. The spectrum ranges from infrequent but highly penetrant variants (mutations) causing mendelian forms of nephrolithiasis (monogenic traits) to common but phenotypically mild variants associated with nephrolithiasis (polygenic traits). About two-thirds of the genes currently known to be associated with nephrolithiasis code for membrane proteins or enzymes involved in renal tubular transport. The thick ascending limb of Henle and connecting tubules are of paramount importance for renal water and electrolyte handling, urinary concentration and maintenance of acid–base homeostasis. In most instances, pathogenic variants in genes involved in thick ascending limb of Henle and connecting tubule function result in phenotypically severe disease, frequently accompanied by nephrocalcinosis with progressive CKD and to a variable degree by nephrolithiasis. The aim of this article is to review the current knowledge on kidney stone disease associated with inherited defects in the thick ascending loop of Henle and the connecting tubules. We also highlight recent advances in the field of kidney stone genetics that have implications beyond rare disease, offering new insights into the most common type of kidney stone disease, i.e., idiopathic calcium stone disease.
Literature
1.
Clubbe WH (1874) Family disposition to urinary concretions. Lancet 1:823
2.
Resnick M, Pridgen DB, Goodman HO (1968) Genetic predisposition to formation of calcium oxalate renal calculi. N Engl J Med 278(24):1313–1318CrossRefPubMed
3.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8(10):1568–1573PubMed
4.
Guerra A, Ticinesi A, Allegri F, Nouvenne A, Pinelli S, Lauretani F, Maggio M, Cervellin G, Borghi L, Meschi T (2017) Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study. Urolithiasis 45(6):525–533CrossRefPubMed
5.
Goldfarb DS, Fischer ME, Keich Y, Goldberg J (2005) A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67(3):1053–1061CrossRefPubMed
6.
Edvardsson VO, Palsson R, Indridason OS, Thorvaldsson S, Stefansson K (2009) Familiality of kidney stone disease in Iceland. Scand J Urol Nephrol 43(5):420–424CrossRefPubMed
7.
Oddsson A, Sulem P, Helgason H, Edvardsson VO, Thorleifsson G, Sveinbjornsson G, Haraldsdottir E, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Masson G, Holm H, Gudbjartsson DF, Thorsteinsdottir U, Indridason OS, Palsson R, Stefansson K (2015) Common and rare variants associated with kidney stones and biochemical traits. Nat Commun 6:7975CrossRefPubMed
8.
Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt F, d’Ancona FC, den Heijer M, Franzson L, Christiansen C, Alexandersen P, Rafnar T, Kristjansson K, Sigurdsson G, Kiemeney LA, Bodvarsson M, Indridason OS, Palsson R, Kong A, Thorsteinsdottir U, Stefansson K (2009) Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41(8):926–930CrossRefPubMed
9.
Urabe Y, Tanikawa C, Takahashi A, Okada Y, Morizono T, Tsunoda T, Kamatani N, Kohri K, Chayama K, Kubo M, Nakamura Y, Matsuda K (2012) A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible Loci at 5q35.3, 7p14.3, and 13q14.1. PLoS Genet 8(3):e1002541CrossRefPubMedPubMedCentral
10.
Gee HY, Jun I, Braun DA, Lawson JA, Halbritter J, Shril S, Nelson CP, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Sayer JA, Milosevic D, Baum M, Tasic V, Lee MG, Hildebrandt F (2016) Mutations in SLC26A1 cause nephrolithiasis. Am J Hum Genet 98(6):1228–1234CrossRefPubMedPubMedCentral
11.
Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, Wassner AJ, Nelson CP, Tasic V, Sayer JA, Hildebrandt F (2015) Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol 26(3):543–551CrossRefPubMed
12.
13.
Mohebbi N, Ferraro PM, Gambaro G, Unwin R (2017) Tubular and genetic disorders associated with kidney stones. Urolithiasis 45(1):127–137CrossRefPubMed
14.
Randall A (1936) An hypothesis for the origin of renal calculus. N Engl J Med 214(6):234–242CrossRef
15.
Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Investig 111(5):607–616CrossRefPubMedPubMedCentral
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Greger R, Schlatter E (1981) Presence of luminal K+, a prerequisite for active NaCl transport in the cortical thick ascending limb of Henle’s loop of rabbit kidney. Pflugers Arch 392(1):92–94CrossRefPubMed
27.
28.
29.
Hebert SC, Andreoli TE (1986) Ionic conductance pathways in the mouse medullary thick ascending limb of Henle. The paracellular pathway and electrogenic Cl− absorption. J Gen Physiol 87(4):567–590CrossRefPubMed
30.
31.
32.
33.
Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285(5424):103–106CrossRefPubMed
34.
Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, Vitzthum H, Suzuki Y, Luk JM, Becker C, Schlingmann KP, Schmid M, Rodriguez-Soriano J, Ariceta G, Cano F, Enriquez R, Juppner H, Bakkaloglu SA, Hediger MA, Gallati S, Neuhauss SC, Nurnberg P, Weber S (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79(5):949–957. https://​doi.​org/​10.​1086/​508617 CrossRefPubMedPubMedCentral
35.
36.
37.
38.
39.
40.
41.
42.
43.
Loupy A, Ramakrishnan SK, Wootla B, Chambrey R, de la Faille R, Bourgeois S, Bruneval P, Mandet C, Christensen EI, Faure H, Cheval L, Laghmani K, Collet C, Eladari D, Dodd RH, Ruat M, Houillier P (2012) PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Investig 122(9):3355–3367. https://​doi.​org/​10.​1172/​JCI57407 CrossRefPubMedPubMedCentral
44.
45.
46.
47.
Devuyst O, Olinger E, Rampoldi L (2017) Uromodulin: from physiology to rare and complex kidney disorders. Nat Rev Nephrol 13(9):525–544CrossRefPubMed
48.
Trudu M, Janas S, Lanzani C, Debaix H, Schaeffer C, Ikehata M, Citterio L, Demaretz S, Trevisani F, Ristagno G, Glaudemans B, Laghmani K, Dell’Antonio G, team S, Loffing J, Rastaldi MP, Manunta P, Devuyst O, Rampoldi L (2013) Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med 19(12):1655–1660. https://​doi.​org/​10.​1038/​nm.​3384 CrossRefPubMed
49.
Mutig K, Kahl T, Saritas T, Godes M, Persson P, Bates J, Raffi H, Rampoldi L, Uchida S, Hille C, Dosche C, Kumar S, Castaneda-Bueno M, Gamba G, Bachmann S (2011) Activation of the bumetanide-sensitive Na+, K+, 2Cl− cotransporter (NKCC2) is facilitated by Tamm–Horsfall protein in a chloride-sensitive manner. J Biol Chem 286(34):30200–30210. https://​doi.​org/​10.​1074/​jbc.​M111.​222968 CrossRefPubMedPubMedCentral
50.
51.
52.
53.
Garimella PS, Bartz TM, Ix JH, Chonchol M, Shlipak MG, Devarajan P, Bennett MR, Sarnak MJ (2017) Urinary uromodulin and risk of urinary tract infections: the cardiovascular health study. Am J Kidney Dis 69(6):744–751CrossRefPubMed
54.
55.
56.
57.
58.
Smith AN, Lovering RC, Futai M, Takeda J, Brown D, Karet FE (2003) Revised nomenclature for mammalian vacuolar-type H+-ATPase subunit genes. Mol Cell 12(4):801–803CrossRefPubMed
59.
Miller RL, Zhang P, Smith M, Beaulieu V, Paunescu TG, Brown D, Breton S, Nelson RD (2005) V-ATPase B1-subunit promoter drives expression of EGFP in intercalated cells of kidney, clear cells of epididymis and airway cells of lung in transgenic mice. Am J Physiol Cell Physiol 288(5):C1134–C1144CrossRefPubMed
60.
61.
Brochard K, Boyer O, Blanchard A, Loirat C, Niaudet P, Macher MA, Deschenes G, Bensman A, Decramer S, Cochat P, Morin D, Broux F, Caillez M, Guyot C, Novo R, Jeunemaitre X, Vargas-Poussou R (2009) Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. Nephrol Dial Transplant 24(5):1455–1464. https://​doi.​org/​10.​1093/​ndt/​gfn689 CrossRefPubMed
62.
63.
Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP (1996) Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14(2):152–156CrossRefPubMed
64.
Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (1996) Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2Cl cotransporter NKCC2. Nat Genet 13(2):183–188CrossRefPubMed
65.
Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet 17(2):171–178CrossRefPubMed
66.
Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T (2002) Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet 360(9334):692–694CrossRefPubMed
67.
Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NV, Antignac C, Sudbrak R, Kispert A, Hildebrandt F (2001) Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29(3):310–314CrossRefPubMed
68.
69.
70.
71.
Laghmani K, Beck BB, Yang SS, Seaayfan E, Wenzel A, Reusch B, Vitzthum H, Priem D, Demaretz S, Bergmann K, Duin LK, Gobel H, Mache C, Thiele H, Bartram MP, Dombret C, Altmuller J, Nurnberg P, Benzing T, Levtchenko E, Seyberth HW, Klaus G, Yigit G, Lin SH, Timmer A, de Koning TJ, Scherjon SA, Schlingmann KP, Bertrand MJ, Rinschen MM, de Backer O, Konrad M, Komhoff M (2016) Polyhydramnios, transient antenatal Bartter’s syndrome, and MAGED2 Mutations. N Engl J Med 374(19):1853–1863CrossRefPubMed
72.
Colussi G, De Ferrari ME, Tedeschi S, Prandoni S, Syren ML, Civati G (2002) Bartter syndrome type 3: an unusual cause of nephrolithiasis. Nephrol Dial Transplant 17(3):521–523CrossRefPubMed
73.
74.
Jeck N, Konrad M, Hess M, Seyberth HW (2000) The diuretic- and Bartter-like salt-losing tubulopathies. Nephrol Dial Transplant 15 Suppl 6:19–20CrossRef
75.
Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus GG, Konrad M, Seyberth HW (2002) Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112(3):183–190CrossRefPubMed
76.
77.
Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, Deschenes G, Kwon T, Bertholet-Thomas A, Bobrie G, Borde JS, Bourdat-Michel G, Decramer S, Cailliez M, Krug P, Cozette P, Delbet JD, Dubourg L, Chaveau D, Fila M, Jourde-Chiche N, Knebelmann B, Lavocat MP, Lemoine S, Djeddi D, Llanas B, Louillet F, Merieau E, Mileva M, Mota-Vieira L, Mousson C, Nobili F, Novo R, Roussey-Kesler G, Vrillon I, Walsh SB, Teulon J, Blanchard A, Vargas-Poussou R (2017) Clinical and genetic spectrum of Bartter syndrome type 3. J Am Soc Nephrol 28(8):2540–2552. https://​doi.​org/​10.​1681/​ASN.​2016101057 CrossRefPubMedPubMedCentral
78.
Li D, Tian L, Hou C, Kim CE, Hakonarson H, Levine MA (2016) Association of mutations in SLC12A1 encoding the NKCC2 cotransporter with neonatal primary hyperparathyroidism. J Clin Endocrinol Metab 101(5):2196–2200CrossRefPubMedPubMedCentral
79.
Wongsaengsak S, Vidmar AP, Addala A, Kamil ES, Sequeira P, Fass B, Pitukcheewanont P (2017) A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients. Bone 97:121–125CrossRefPubMed
80.
Weber S, Schneider L, Peters M, Misselwitz J, Ronnefarth G, Boswald M, Bonzel KE, Seeman T, Sulakova T, Kuwertz-Broking E, Gregoric A, Palcoux JB, Tasic V, Manz F, Scharer K, Seyberth HW, Konrad M (2001) Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 12(9):1872–1881PubMed
81.
Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47(5):1419–1425CrossRefPubMed
82.
Wolf MT, Dotsch J, Konrad M, Boswald M, Rascher W (2002) Follow-up of five patients with FHHNC due to mutations in the Paracellin-1 gene. Pediatr Nephrol 17(8):602–608CrossRefPubMed
83.
84.
Tasic V, Dervisov D, Koceva S, Weber S, Konrad M (2005) Hypomagnesemia with hypercalciuria and nephrocalcinosis: case report and a family study. Pediatr Nephrol 20(7):1003–1006CrossRefPubMed
85.
86.
87.
Ure ME, Heydari E, Pan W, Ramesh A, Rehman S, Morgan C, Pinsk M, Erickson R, Herrmann JM, Dimke H, Cordat E, Lemaire M, Walter M, Alexander RT (2017) A variant in a cis-regulatory element enhances claudin-14 expression and is associated with pediatric-onset hypercalciuria and kidney stones. Hum Mutat 38(6):649–657. https://​doi.​org/​10.​1002/​humu.​23202 CrossRefPubMed
88.
Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML (2002) Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 13(10):2517–2523CrossRefPubMed
89.
Ding Q, Fan B, Shi Y, Fan Z, Ding L, Li F, Tu W, Jin X, Qin C, Cao Q, Yuan Q, Wang J, Ouyang J (2017) Calcium-sensing receptor genetic polymorphisms and risk of developing nephrolithiasis in a Chinese population. Urol Int 99(3):331–337CrossRefPubMed
90.
Vezzoli G, Terranegra A, Arcidiacono T, Gambaro G, Milanesi L, Mosca E, Soldati L (2010) Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant 25(7):2245–2252CrossRefPubMed
91.
Vezzoli G, Terranegra A, Aloia A, Arcidiacono T, Milanesi L, Mosca E, Mingione A, Spotti D, Cusi D, Hou J, Hendy GN, Soldati L, Paloschi V, Dogliotti E, Brasacchio C, Dell’Antonio G, Montorsi F, Bertini R, Bellinzoni P, Guazzoni G, Borghi L, Guerra A, Allegri F, Ticinesi A, Meschi T, Nouvenne A, Lupo A, Fabris A, Gambaro G, Strazzullo P, Rendina D, De Filippo G, Brandi ML, Croppi E, Cianferotti L, Trinchieri A, Caudarella R, Cupisti A, Anglani F, Del Prete D (2013) Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis. J Clin Endocrinol Metab 98(9):3839–3847CrossRefPubMedPubMedCentral
92.
Shakhssalim N, Kazemi B, Basiri A, Houshmand M, Pakmanesh H, Golestan B, Eilanjegh AF, Kashi AH, Kilani M, Azadvari M (2010) Association between calcium-sensing receptor gene polymorphisms and recurrent calcium kidney stone disease: a comprehensive gene analysis. Scand J Urol Nephrol 44(6):406–412CrossRefPubMed
93.
Hamilton DC, Grover VK, Smith CA, Cole DE (2009) Heterogeneous disease modeling for Hardy–Weinberg disequilibrium in case–control studies: application to renal stones and calcium-sensing receptor polymorphisms. Ann Hum Genet 73(2):176–183CrossRefPubMed
94.
Chou YH, Woon PY, Chen WC, Hsu YW, Chang JM, Hwang DY, Chiu YC, Kuo HC, Chang WP, Hou MF, Liu ME, Chang JG, Chang WC (2011) A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis. PLoS One 6(9):e25227CrossRefPubMedPubMedCentral
95.
Gudbjartsson DF, Holm H, Indridason OS, Thorleifsson G, Edvardsson V, Sulem P, de Vegt F, d’Ancona FC, den Heijer M, Wetzels JF, Franzson L, Rafnar T, Kristjansson K, Bjornsdottir US, Eyjolfsson GI, Kiemeney LA, Kong A, Palsson R, Thorsteinsdottir U, Stefansson K (2010) Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet 6(7):e1001039CrossRefPubMedPubMedCentral
96.
97.
Karet FE, Finberg KE, Nelson RD, Nayir A, Mocan H, Sanjad SA, Rodriguez-Soriano J, Santos F, Cremers CW, Di Pietro A, Hoffbrand BI, Winiarski J, Bakkaloglu A, Ozen S, Dusunsel R, Goodyer P, Hulton SA, Wu DK, Skvorak AB, Morton CC, Cunningham MJ, Jha V, Lifton RP (1999) Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 21(1):84–90CrossRefPubMed
98.
Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, Ozen S, Hulton SA, Sanjad SA, Al-Sabban EA, Lifton RP, Scherer SW, Karet FE (2000) Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 26(1):71–75CrossRefPubMed
99.
Enerback S, Nilsson D, Edwards N, Heglind M, Alkanderi S, Ashton E, Deeb A, Kokash FEB, Bakhsh ARA, Van’t Hoff W, Walsh SB, D’Arco F, Daryadel A, Bourgeois S, Wagner CA, Kleta R, Bockenhauer D, Sayer JA (2018) Acidosis and deafness in patients with recessive mutations in FOXI1. J Am Soc Nephrol 29(3):1041–1048PubMed
100.
Karet FE, Gainza FJ, Gyory AZ, Unwin RJ, Wrong O, Tanner MJ, Nayir A, Alpay H, Santos F, Hulton SA, Bakkaloglu A, Ozen S, Cunningham MJ, di Pietro A, Walker WG, Lifton RP (1998) Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci USA 95(11):6337–6342CrossRefPubMedPubMedCentral
101.
Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE (1983) Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 80(9):2752–2756CrossRefPubMedPubMedCentral
102.
Sly WS, Whyte MP, Sundaram V, Tashian RE, Hewett-Emmett D, Guibaud P, Vainsel M, Baluarte HJ, Gruskin A, Al-Mosawi M et al (1985) Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 313(3):139–145CrossRefPubMed
103.
Mohebbi N, Wagner CA (2018) Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol 31(4):511–522CrossRefPubMed
104.
Palazzo V, Provenzano A, Becherucci F, Sansavini G, Mazzinghi B, Orlandini V, Giunti L, Roperto RM, Pantaleo M, Artuso R, Andreucci E, Bargiacchi S, Traficante G, Stagi S, Murer L, Benetti E, Emma F, Giordano M, Rivieri F, Colussi G, Penco S, Manfredini E, Caruso MR, Garavelli L, Andrulli S, Vergine G, Miglietti N, Mancini E, Malaventura C, Percesepe A, Grosso E, Materassi M, Romagnani P, Giglio S (2017) The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int 91(5):1243–1255CrossRefPubMed
105.
Vargas-Poussou R, Houillier P, Le Pottier N, Strompf L, Loirat C, Baudouin V, Macher MA, Dechaux M, Ulinski T, Nobili F, Eckart P, Novo R, Cailliez M, Salomon R, Nivet H, Cochat P, Tack I, Fargeot A, Bouissou F, Kesler GR, Lorotte S, Godefroid N, Layet V, Morin G, Jeunemaitre X, Blanchard A (2006) Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J Am Soc Nephrol 17(5):1437–1443CrossRefPubMed
106.
Rysava R, Tesar V, Jirsa M Jr, Brabec V, Jarolim P (1997) Incomplete distal renal tubular acidosis coinherited with a mutation in the band 3 (AE1) gene. Nephrol Dial Transplant 12(9):1869–1873CrossRefPubMed
107.
Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, Tanner MJ (1997) Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Investig 100(7):1693–1707CrossRefPubMedPubMedCentral
108.
Wrong O, Davies HE (1959) The excretion of acid in renal disease. Q J Med 28(110):259–313PubMed
109.
Escobar LI, Simian C, Treard C, Hayek D, Salvador C, Guerra N, Matos M, Medeiros M, Enciso S, Camargo MD, Vargas-Poussou R (2016) Mutations in ATP6V1B1 and ATP6V0A4 genes cause recessive distal renal tubular acidosis in Mexican families. Mol Genet Genom Med 4(3):303–311CrossRef
110.
Berrettini S, Neri E, Forli F, Panconi M, Massimetti M, Ravecca F, Sellari-Franceschini S, Bartolozzi C (2001) Large vestibular aqueduct in distal renal tubular acidosis. High-resolution MR in three cases. Acta Radiol 42(3):320–322PubMed
111.
Berrettini S, Forli F, Franceschini SS, Ravecca F, Massimetti M, Neri E (2002) Distal renal tubular acidosis associated with isolated large vestibular aqueduct and sensorineural hearing loss. Ann Otol Rhinol Laryngol 111(5 Pt 1):385–391CrossRefPubMed
112.
Berrettini S, Forli F, Bogazzi F, Neri E, Salvatori L, Casani AP, Franceschini SS (2005) Large vestibular aqueduct syndrome: audiological, radiological, clinical, and genetic features. Am J Otolaryngol 26(6):363–371CrossRefPubMed
113.
Batlle D, Haque SK (2012) Genetic causes and mechanisms of distal renal tubular acidosis. Nephrol Dial Transplant 27(10):3691–3704CrossRefPubMed
114.
Alper SL (2010) Familial renal tubular acidosis. J Nephrol 23(Suppl 16):S57–S76PubMed
115.
Bruce LJ, Wrong O, Toye AM, Young MT, Ogle G, Ismail Z, Sinha AK, McMaster P, Hwaihwanje I, Nash GB, Hart S, Lavu E, Palmer R, Othman A, Unwin RJ, Tanner MJ (2000) Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells. Biochem J 350(Pt 1):41–51CrossRefPubMedPubMedCentral
116.
Awad M, Al-Ashwal AA, Sakati N, Al-Abbad AA, Bin-Abbas BS (2002) Long-term follow up of carbonic anhydrase II deficiency syndrome. Saudi Med J 23(1):25–29PubMed
117.
Goodman AD, Lemann J Jr, Lennon EJ, Relman AS (1965) Production, excretion, and net balance of fixed acid in patients with renal acidosis. J Clin Investig 44:495–506CrossRefPubMedPubMedCentral
118.
Preminger GM, Sakhaee K, Pak CY (1987) Hypercalciuria and altered intestinal calcium absorption occurring independently of vitamin D in incomplete distal renal tubular acidosis. Metabolism 36(2):176–179CrossRefPubMed
119.
Bushinsky DA, Frick KK (2000) The effects of acid on bone. Curr Opin Nephrol Hypertens 9(4):369–379CrossRefPubMed
120.
Alexander RT, Cordat E, Chambrey R, Dimke H, Eladari D (2016) Acidosis and urinary calcium excretion: insights from genetic disorders. J Am Soc Nephrol 27(12):3511–3520CrossRefPubMedPubMedCentral
121.
Daudon M, Bouzidi H, Bazin D (2010) Composition and morphology of phosphate stones and their relation with etiology. Urol Res 38(6):459–467CrossRefPubMed
122.
Dessombz A, Letavernier E, Haymann JP, Bazin D, Daudon M (2015) Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis. J Urol 193(5):1564–1569CrossRefPubMed
123.
Domrongkitchaiporn S, Pongsakul C, Stitchantrakul W, Sirikulchayanonta V, Ongphiphadhanakul B, Radinahamed P, Karnsombut P, Kunkitti N, Ruang-raksa C, Rajatanavin R (2001) Bone mineral density and histology in distal renal tubular acidosis. Kidney Int 59(3):1086–1093CrossRefPubMed
124.
Disthabanchong S, Domrongkitchaiporn S, Sirikulchayanonta V, Stitchantrakul W, Karnsombut P, Rajatanavin R (2004) Alteration of noncollagenous bone matrix proteins in distal renal tubular acidosis. Bone 35(3):604–613CrossRefPubMed
125.
Domrongkitchaiporn S, Pongskul C, Sirikulchayanonta V, Stitchantrakul W, Leeprasert V, Ongphiphadhanakul B, Radinahamed P, Rajatanavin R (2002) Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis. Kidney Int 62(6):2160–2166CrossRefPubMed
126.
Nash MA, Torrado AD, Greifer I, Spitzer A, Edelmann CM Jr (1972) Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis. J Pediatr 80(5):738–748CrossRefPubMed
127.
McSherry E, Morris RC Jr (1978) Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Investig 61(2):509–527CrossRefPubMedPubMedCentral
128.
Preminger GM, Sakhaee K, Pak CY (1988) Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate. J Urol 139(2):240–242CrossRefPubMed
129.
Greenberg AJ, McNamara H, McCrory WW (1966) Metabolic balance studies in primary renal tubular acidosis: effects of acidosis on external calcium and phosphorus balances. J Pediatr 69(4):610–618CrossRefPubMed
130.
Wikstrom B, Backman U, Danielson BG, Fellstrom B, Johansson G, Ljunghall S (1983) Ambulatory diagnostic evaluation of 389 recurrent renal stone formers. A proposal for clinical classification and investigation. Klin Wochenschr 61(2):85–90CrossRefPubMed
131.
Ito H, Kotake T, Suzuki F (1993) Incidence and clinical features of renal tubular acidosis-1 in urolithiasis. Urol Int 50(2):82–85CrossRefPubMed
132.
Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734CrossRefPubMedPubMedCentral
133.
Dhayat NA, Gradwell MW, Pathare G, Anderegg M, Schneider L, Luethi D, Mattmann C, Moe OW, Vogt B, Fuster DG (2017) Furosemide/fludrocortisone test and clinical parameters to diagnose incomplete distal renal tubular acidosis in kidney stone formers. Clin J Am Soc Nephrol 12(9):1507–1517CrossRefPubMedPubMedCentral
134.
Pak CY, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115(1):26–32CrossRefPubMed
135.
Pak CY, Poindexter JR, Peterson RD, Heller HJ (2004) Biochemical and physicochemical presentations of patients with brushite stones. J Urol 171(3):1046–1049CrossRefPubMed
136.
Zhang J, Fuster DG, Cameron MA, Quinones H, Griffith C, Xie XS, Moe OW (2014) Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit. Am J Physiol Ren Physiol 307(9):F1063–F1071CrossRef
137.
Dhayat NA, Schaller A, Albano G, Poindexter J, Griffith C, Pasch A, Gallati S, Vogt B, Moe OW, Fuster DG (2016) The vacuolar H+-ATPase B1 subunit polymorphism p.E161K associates with impaired urinary acidification in recurrent stone formers. J Am Soc Nephrol 27(5):1544–1554CrossRefPubMed
138.
Mohebbi N, Vargas-Poussou R, Hegemann SC, Schuknecht B, Kistler AD, Wuthrich RP, Wagner CA (2013) Homozygous and compound heterozygous mutations in the ATP6V1B1 gene in patients with renal tubular acidosis and sensorineural hearing loss. Clin Genet 83(3):274–278CrossRefPubMed
139.
Fuster DG, Zhang J, Xie XS, Moe OW (2008) The vacuolar-ATPase B1 subunit in distal tubular acidosis: novel mutations and mechanisms for dysfunction. Kidney Int 73(10):1151–1158CrossRefPubMed
Metadata
Title
Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules
Authors
Nicolas Faller
Nasser A. Dhayat
Daniel G. Fuster
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 1/2019
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-018-1097-z

Other articles of this Issue 1/2019

Urolithiasis 1/2019 Go to the issue

Invited Review

Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms

Invited Review

Urinary proteome in inherited nephrolithiasis

Preface

Empirical therapy or precision medicine for kidney stone formers in the ‘-omics’ era?

Invited Review

Cystinuria: genetic aspects, mouse models, and a new approach to therapy

Invited Review

Empiric therapy for kidney stones

Invited Review

Genetics of common complex kidney stone disease: insights from genome-wide association studies